UnitedHealth Group Incorporated (NYSE:UNH) Releases FY17 Earnings Guidance

UnitedHealth Group Incorporated (NYSE:UNH) issued an update on its FY17 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $10.00 for the period, compared to the Thomson Reuters consensus estimate of $9.86.

UnitedHealth Group Incorporated (UNH) traded up 1.65% during mid-day trading on Friday, reaching $212.60. The company had a trading volume of 4,385,348 shares. UnitedHealth Group Incorporated has a one year low of $136.22 and a one year high of $212.77. The firm has a market capitalization of $210.26 billion, a P/E ratio of 24.14 and a beta of 0.63. The firm’s 50-day moving average is $198.15 and its 200-day moving average is $186.99.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business posted $2.17 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.99 earnings per share for the current fiscal year.

A number of research firms have recently commented on UNH. Mizuho reaffirmed a buy rating on shares of UnitedHealth Group in a research note on Tuesday. Oppenheimer Holdings, Inc. increased their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the stock an outperform rating in a research note on Wednesday, October 18th. Sanford C. Bernstein reissued an outperform rating and issued a $219.00 price objective (up previously from $210.00) on shares of UnitedHealth Group in a research note on Thursday, October 19th. Argus increased their price objective on UnitedHealth Group from $215.00 to $230.00 and gave the stock a buy rating in a research note on Thursday, October 19th. Finally, Piper Jaffray Companies upped their target price on UnitedHealth Group to $228.00 and gave the stock an overweight rating in a report on Tuesday, October 17th. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. UnitedHealth Group has an average rating of Buy and a consensus target price of $215.27.

In other news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the sale, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The disclosure for this sale can be found here. Insiders sold a total of 77,149 shares of company stock worth $15,182,242 over the last three months. Corporate insiders own 0.89% of the company’s stock.

WARNING: This article was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2017/10/28/unitedhealth-group-incorporated-unh-issues-fy17-earnings-guidance.html.

Institutional investors have recently bought and sold shares of the stock. Intellectus Partners LLC increased its holdings in UnitedHealth Group by 18.2% in the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after purchasing an additional 126 shares during the last quarter. Bank of Nova Scotia increased its holdings in UnitedHealth Group by 7.8% in the 2nd quarter. Bank of Nova Scotia now owns 447,793 shares of the healthcare conglomerate’s stock valued at $83,030,000 after purchasing an additional 32,405 shares during the last quarter. M&R Capital Management Inc. increased its holdings in UnitedHealth Group by 14.8% in the 2nd quarter. M&R Capital Management Inc. now owns 1,550 shares of the healthcare conglomerate’s stock valued at $299,000 after purchasing an additional 200 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its holdings in UnitedHealth Group by 6.5% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 367,044 shares of the healthcare conglomerate’s stock valued at $68,070,000 after purchasing an additional 22,428 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in UnitedHealth Group by 4.7% in the 2nd quarter. Assetmark Inc. now owns 118,027 shares of the healthcare conglomerate’s stock valued at $21,885,000 after purchasing an additional 5,317 shares during the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply